{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:58:46Z","timestamp":1783605526859,"version":"3.55.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12186-6","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T17:02:30Z","timestamp":1764176550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antimicrobial resistance trends of Escherichia coli and Staphylococcus aureus isolated from clinical blood cultures in Namibia: a nine-year (2011-2019) retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Erastus Hanganeni H.","family":"Haindongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti J.","family":"Hakanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Vainio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Vuopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Hedimbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"12186_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"key":"12186_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz123","author":"K Inagaki","year":"2019","unstructured":"Inagaki K, Lucar J, Blackshear C, Hobbs CV. Methicillin-susceptible and methicillin-resistant Staphylococcus aureus Bacteremia: nationwide estimates of 30-day readmission, In-hospital mortality, length of stay, and cost in the United States. Clin Infect Dis. 2019. https:\/\/doi.org\/10.1093\/cid\/ciz123.","journal-title":"Clin Infect Dis"},{"key":"12186_CR3","doi-asserted-by":"publisher","unstructured":"Holmes CL, Anderson MT, Mobley HLT, Bachman MA. Pathogenesis of gram-negative bacteremia. Clin Microbiol Rev. 2021;34. https:\/\/doi.org\/10.1128\/CMR.00234-20.","DOI":"10.1128\/CMR.00234-20"},{"key":"12186_CR4","doi-asserted-by":"publisher","unstructured":"Zellweger RM, Basnyat B, Shrestha P, Prajapati KG, Dongol S, Sharma PK, et al. Changing antimicrobial resistance trends in Kathmandu, Nepal: a 23-year retrospective analysis of bacteraemia. Front Med (Lausanne). 2018;5. https:\/\/doi.org\/10.3389\/fmed.2018.00262.","DOI":"10.3389\/fmed.2018.00262"},{"key":"12186_CR5","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S1473-3099(19)30414-1","volume":"19","author":"U Okomo","year":"2019","unstructured":"Okomo U, Akpalu ENK, Le Doare K, Roca A, Cousens S, Jarde A, et al. Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in Sub-Saharan Africa: a systematic review and meta-analysis in line with the STROBE-NI reporting guidelines. Lancet Infect Dis. 2019;19:1219\u201334. https:\/\/doi.org\/10.1016\/S1473-3099(19)30414-1.","journal-title":"Lancet Infect Dis"},{"key":"12186_CR6","volume-title":"European observatory on health Systems and policies","author":"M Anderson","year":"2019","unstructured":"Anderson M, Clift C, Schulze K, Sagan A, Nahrgang S, Ait Ouakrim D, et al. Averting the AMR crisis: what are the avenues for policy action for countries in Europe? In: European observatory on health systems and policies. Copenhagen (Denmark); 2019."},{"key":"12186_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jinf.2021.08.048","volume":"83","author":"J Takata","year":"2021","unstructured":"Takata J, Kelly DF, Sadarangani M, Jeffery K, Drysdale SB. 14-year trends and resistance patterns of blood and cerebrospinal fluid cultures in children under three years old. J Infect. 2021;83:533\u201341. https:\/\/doi.org\/10.1016\/j.jinf.2021.08.048.","journal-title":"The J Infect"},{"key":"12186_CR8","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.2147\/IDR.S342753","volume":"15","author":"S Kariuki","year":"2022","unstructured":"Kariuki S, Kering K, Wairimu C, Onsare R, Mbae C. Antimicrobial resistance rates and surveillance in Sub-Saharan Africa: where are we now? Infect Drug Resist. 2022;15:3589\u2013609. https:\/\/doi.org\/10.2147\/IDR.S342753.","journal-title":"Infect Drug Resist"},{"key":"12186_CR9","unstructured":"WHO. Global antimicrobial resistance and use surveillance system (GLASS) report 2021. World Health Organization. 2021."},{"key":"12186_CR10","unstructured":"World Health Organization. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2017-2018. 2018."},{"key":"12186_CR11","unstructured":"WHO. Global action plan on antimicrobial resistance. WHO Report. 2015."},{"key":"12186_CR12","doi-asserted-by":"publisher","first-page":"e934","DOI":"10.1016\/S2214-109X(18)30325-5","volume":"6","author":"N Matsunaga","year":"2018","unstructured":"Matsunaga N, Hayakawa K. Estimating the impact of antimicrobial resistance. Lancet Glob Health. 2018;6:e934\u20135. https:\/\/doi.org\/10.1016\/S2214-109X(18)30325-5.","journal-title":"Lancet Glob Health"},{"key":"12186_CR13","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2025","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 35th ed. CLSI supplement M100; 2025.","edition":"35th edn"},{"key":"12186_CR14","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/jac\/dkad092","volume":"78","author":"PY Woh","year":"2023","unstructured":"Woh PY, Yeung MPS, Goggins WB. Multiple antibiotic resistance index (MARI) of human-isolated Salmonella species: a practical bacterial antibiotic surveillance tool. J Antimicrob Chemother. 2023;78:1295\u201399. https:\/\/doi.org\/10.1093\/jac\/dkad092.","journal-title":"The J Antimicrob Chemother"},{"key":"12186_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol And Infect"},{"key":"12186_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12887-017-0892-y","volume":"17","author":"T G\/Eyesus","year":"2017","unstructured":"G\/Eyesus T, Moges F, Eshetie S, Yeshitela B, Abate E. Bacterial etiologic agents causing neonatal sepsis and associated risk factors in Gondar, Northwest Ethiopia. BMC Pediatr. 2017;17:137. https:\/\/doi.org\/10.1186\/s12887-017-0892-y.","journal-title":"BMC Pediatr"},{"key":"12186_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2431-10-39","volume":"10","author":"N Kayange","year":"2010","unstructured":"Kayange N, Kamugisha E, Mwizamholya DL, Jeremiah S, Mshana SE. Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza- Tanzania. BMC Pediatr. 2010;10:39. https:\/\/doi.org\/10.1186\/1471-2431-10-39.","journal-title":"BMC Pediatr"},{"key":"12186_CR18","doi-asserted-by":"publisher","first-page":"e390.1","DOI":"10.1016\/j.cmi.2022.10.021","volume":"29","author":"A Baraz","year":"2023","unstructured":"Baraz A, Chowers M, Nevo D, Obolski U. The time-varying association between previous antibiotic use and antibiotic resistance. Clin Microbiol Infect. 2023;29:390.e1\u2013390. https:\/\/doi.org\/10.1016\/j.cmi.2022.10.021.","journal-title":"Clin Microbiol And Infect"},{"key":"12186_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1684-1182(10)60054-0","volume":"43","author":"ML Towns","year":"2010","unstructured":"Towns ML, Jarvis WR, Hsueh P-R. Guidelines on blood cultures. J Microbiol Immunol Infect. 2010;43:347\u201349. https:\/\/doi.org\/10.1016\/S1684-1182(10)60054-0.","journal-title":"J Microbiol Immunol Infect"},{"key":"12186_CR20","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1016\/S2214-109X(22)00288-1","volume":"10","author":"D Pillay","year":"2022","unstructured":"Pillay D. Combating antimicrobial resistance in neonatal infections: a South African perspective. Lancet Glob Health. 2022;10:e1082\u20133. https:\/\/doi.org\/10.1016\/S2214-109X(22)00288-1.","journal-title":"Lancet Glob Health"},{"key":"12186_CR21","doi-asserted-by":"publisher","first-page":"e1170","DOI":"10.1016\/S2214-109X(22)00246-7","volume":"10","author":"RC Mashau","year":"2022","unstructured":"Mashau RC, Meiring ST, Dramowski A, Magobo RE, Quan VC, Perovic O, et al. Culture-confirmed neonatal bloodstream infections and meningitis in South Africa, 2014\u201319: a cross-sectional study. Lancet Glob Health. 2022;10:e1170\u20138. https:\/\/doi.org\/10.1016\/S2214-109X(22)00246-7.","journal-title":"Lancet Glob Health"},{"key":"12186_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cmi.2015.01.003","volume":"21","author":"O Opota","year":"2015","unstructured":"Opota O, Croxatto A, Prod\u2019hom G, Greub G. Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect. 2015;21:313\u201322. https:\/\/doi.org\/10.1016\/j.cmi.2015.01.003.","journal-title":"Clin Microbiol And Infect"},{"key":"12186_CR23","doi-asserted-by":"crossref","unstructured":"Jacob S, Sheehama G, Uushona S. Laboratory sample collection errors at Namibia institute of pathology among state doctors and nurses, Erongo Region, Namibia. Acta Sci Med Sci (ISSN: 2582-0931). 2024;8.","DOI":"10.31080\/ASMS.2024.08.1764"},{"key":"12186_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13756-022-01066-2","volume":"11","author":"EH Haindongo","year":"2022","unstructured":"Haindongo EH, Funtua B, Singu B, Hedimbi M, Kalemeera F, Hamman J, et al. Antimicrobial resistance among bacteria isolated from urinary tract infections in females in Namibia, 2016\u20132017. Antimicrob Resist Infect Control. 2022;11:33. https:\/\/doi.org\/10.1186\/s13756-022-01066-2.","journal-title":"Antimicrob Resist Infect Control"},{"key":"12186_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jgar.2022.11.016","volume":"32","author":"EH Haindongo","year":"2023","unstructured":"Haindongo EH, Ndakolo D, Hedimbi M, Vainio O, Hakanen A, Vuopio J. Antimicrobial resistance prevalence of Escherichia coli and Staphylococcus aureus amongst bacteremic patients in Africa: a systematic review. J Glob Antimicrob Resist. 2023;32:35\u201343. https:\/\/doi.org\/10.1016\/j.jgar.2022.11.016.","journal-title":"J Glob Antimicrob Resist"},{"key":"12186_CR26","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1186\/s12879-022-07768-7","volume":"22","author":"C McCowan","year":"2022","unstructured":"McCowan C, Bakhshi A, McConnachie A, Malcolm W, Barry SJ, Santiago VH, et al. E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community. BMC Infect Dis. 2022;22:805. https:\/\/doi.org\/10.1186\/s12879-022-07768-7.","journal-title":"BMC Infect Dis"},{"key":"12186_CR27","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1186\/s12879-019-4295-6","volume":"19","author":"M Mhondoro","year":"2019","unstructured":"Mhondoro M, Ndlovu N, Bangure D, Juru T, Gombe NT, Shambira G, et al. Trends in antimicrobial resistance of bacterial pathogens in Harare, Zimbabwe, 2012\u20132017: a secondary dataset analysis. BMC Infect Dis. 2019;19:746. https:\/\/doi.org\/10.1186\/s12879-019-4295-6.","journal-title":"BMC Infect Dis"},{"key":"12186_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12941-014-0061-1","volume":"14","author":"E Anago","year":"2015","unstructured":"Anago E, Ayi-Fanou L, Akpovi CD, Hounkpe WB, Agassounon-Djikpo Tchibozo M, Bankole HS, et al. Antibiotic resistance and genotype of beta-lactamase producing Escherichia coli in nosocomial infections in Cotonou, Benin. Ann Clin Microbiol Antimicrob. 2015;14:5. https:\/\/doi.org\/10.1186\/s12941-014-0061-1.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"12186_CR29","doi-asserted-by":"publisher","DOI":"10.14744\/SEMB.2018.60352","author":"B Bayraktar","year":"2018","unstructured":"Bayraktar B, Pelit S, Bulut ME, Akta\u015f E. Antibiotic resistance trends of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infections over the years. SiSli Etfal Hastanesi Tip Bulteni\/Med Bull Sisli Hosp. 2018. https:\/\/doi.org\/10.14744\/SEMB.2018.60352.","journal-title":"sisli Etfal Hastanesi Tip bulteni\/Med Bull Of Sisli Hosp"},{"key":"12186_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jpids\/piu014","volume":"4","author":"K Le Doare","year":"2015","unstructured":"Le Doare K, Bielicki J, Heath PT, Sharland M. Systematic review of antibiotic resistance rates among gram-negative bacteria in children with sepsis in resource-limited countries. J Pediatr Infect Dis Soc. 2015;4:11\u201320. https:\/\/doi.org\/10.1093\/jpids\/piu014.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"12186_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13756-019-0673-5","volume":"8","author":"N Droz","year":"2019","unstructured":"Droz N, Hsia Y, Ellis S, Dramowski A, Sharland M, Basmaci R. Bacterial pathogens and resistance causing community acquired paediatric bloodstream infections in low- and middle-income countries: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2019;8:207. https:\/\/doi.org\/10.1186\/s13756-019-0673-5.","journal-title":"Antimicrob Resist Infect Control"},{"key":"12186_CR32","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/S1473-3099(17)30467-X","volume":"18","author":"PCM Williams","year":"2018","unstructured":"Williams PCM, Isaacs D, Berkley JA. Antimicrobial resistance among children in Sub-Saharan Africa. Lancet Infect Dis. 2018;18:e33\u201344. https:\/\/doi.org\/10.1016\/S1473-3099(17)30467-X.","journal-title":"Lancet Infect Dis"},{"key":"12186_CR33","unstructured":"World Health Organization. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020. 2020."},{"key":"12186_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109:309\u201318. https:\/\/doi.org\/10.1179\/2047773215Y.0000000030.","journal-title":"Pathog Glob Health"},{"key":"12186_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijid.2016.11.084","volume":"53","author":"U Theuretzbacher","year":"2016","unstructured":"Theuretzbacher U. Ecology and environmental drivers of antimicrobial resistance. Int J Infect Dis. 2016;53:31. https:\/\/doi.org\/10.1016\/j.ijid.2016.11.084.","journal-title":"Int J Infect Dis"},{"key":"12186_CR36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","volume":"387","author":"AH Holmes","year":"2016","unstructured":"Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387:176\u201387. https:\/\/doi.org\/10.1016\/S0140-6736(15)00473-0.","journal-title":"Lancet"},{"key":"12186_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/cid\/ciy834","volume":"69","author":"P-Y Iroh Tam","year":"2019","unstructured":"Iroh Tam P-Y, Musicha P, Kawaza K, Cornick J, Denis B, Freyne B, et al. Emerging resistance to empiric antimicrobial regimens for pediatric bloodstream infections in Malawi (1998\u20132017). Clin Infect Dis. 2019;69:61\u201368. https:\/\/doi.org\/10.1093\/cid\/ciy834.","journal-title":"Clin Infect Dis"},{"key":"12186_CR38","doi-asserted-by":"publisher","unstructured":"Yardimci AC, Arman D. Prevalence and antimicrobial resistance of bloodstream infections caused by ESKAPEEc pathogens: a five-year analysis. Jundishapur J Microbiol. 2022;15. https:\/\/doi.org\/10.5812\/jjm-122990.","DOI":"10.5812\/jjm-122990"},{"key":"12186_CR39","doi-asserted-by":"publisher","unstructured":"Polemis M, Tryfinopoulou K, Giakkoupi P, Vatopoulos A. Eight-year trends in the relative isolation frequency and antimicrobial susceptibility among bloodstream isolates from Greek hospitals: data from the Greek electronic system for the surveillance of antimicrobial Resistance \u2013 WHONET-Greece, 2010 to 2017. Eurosurveillance. 2020;25. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.34.1900516.","DOI":"10.2807\/1560-7917.ES.2020.25.34.1900516"},{"key":"12186_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/jacm.jacm_26_18","volume":"21","author":"S Ahmed","year":"2019","unstructured":"Ahmed S, Jakribettu R, Rajeevan S, George A, Mariyam KM, Rao S. Five-year trend of bacterial isolates and their antibiotic resistance from automated BACTEC blood culture system from a rural medical college hospital in North Kerala, India: 2012\u20132016. J Acad Clin Microbiologists. 2019;21:10. https:\/\/doi.org\/10.4103\/jacm.jacm_26_18.","journal-title":"J Educ Chang The Acad Clin Microbiologists"},{"key":"12186_CR41","volume-title":"Namibia standard treatment guidelines","author":"Ministry of Health and Social Services","year":"2011","unstructured":"Ministry of Health and Social Services. Namibia standard treatment guidelines. First Edition. 2011.","edition":"First Edition"},{"key":"12186_CR42","doi-asserted-by":"publisher","first-page":"e344.1","DOI":"10.1016\/j.cmi.2014.11.016","volume":"21","author":"AJ Stewardson","year":"2015","unstructured":"Stewardson AJ, Ga\u00efa N, Fran\u00e7ois P, Malhotra-Kumar S, Del\u00e9mont C, Martinez de Tejada B, et al. Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota. Clin Microbiol Infect. 2015;21:344.e1\u2013344.e11. https:\/\/doi.org\/10.1016\/j.cmi.2014.11.016.","journal-title":"Clin Microbiol And Infect"},{"key":"12186_CR43","doi-asserted-by":"publisher","first-page":"7536","DOI":"10.1128\/AAC.01809-16","volume":"60","author":"A Babiker","year":"2016","unstructured":"Babiker A, Sanchez GV, Bhandary S, Bordon JM. Reply to \u201cNitrofurantoin, an excellent empiric choice for outpatient cystitis\u201d. Antimicrob Agents Chemother. 2016;60:7536\u20137536. https:\/\/doi.org\/10.1128\/AAC.01809-16.","journal-title":"Antimicrob Agents Chemother"},{"key":"12186_CR44","doi-asserted-by":"publisher","first-page":"e1250","DOI":"10.1002\/prp2.1250","volume":"12","author":"BS Singu","year":"2024","unstructured":"Singu BS, Pieper CH, Verbeeck RK, Ette EI. Predictors of gentamicin therapy failure in neonates with sepsis. Pharmacol Res Perspect. 2024;12:e1250. https:\/\/doi.org\/10.1002\/prp2.1250.","journal-title":"Pharmacol Res Perspect"},{"key":"12186_CR45","volume-title":"Namibia standard treatment guidelines","author":"Ministry of Health and Social Services","year":"2021","unstructured":"Ministry of Health and Social Services. Namibia standard treatment guidelines. 2nd Edition. 2021.","edition":"2nd Edition"},{"key":"12186_CR46","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3855\/jidc.7329","volume":"10","author":"DD Pereko","year":"2016","unstructured":"Pereko DD, Lubbe MS, Essack SY. Surveillance of antibiotic use in the private sector in Namibia using sales and claims data. J Infect Dev Ctries. 2016;10:1243\u201349. https:\/\/doi.org\/10.3855\/jidc.7329.","journal-title":"J Infect Dev Ctries"},{"key":"12186_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-021-04310-6","author":"BD Johnston","year":"2021","unstructured":"Johnston BD, Thuras P, Porter SB, Anacker M, VonBank B, Vagnone PS, et al. Global molecular epidemiology of carbapenem-resistant Escherichia coli (2002\u20132017). Eur J Clin Microbiol Infect Dis. 2021. https:\/\/doi.org\/10.1007\/s10096-021-04310-6.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"12186_CR48","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jiph.2017.09.020","volume":"11","author":"W Liang","year":"2018","unstructured":"Liang W, Liu H, Duan G-C, Zhao Y, Chen S, Yang H-Y, et al. Emergence and mechanism of carbapenem-resistant Escherichia coli in Henan, China, 2014. J Infect Public Health. 2018;11:347\u201351. https:\/\/doi.org\/10.1016\/j.jiph.2017.09.020.","journal-title":"J Infect Public Health"},{"key":"12186_CR49","doi-asserted-by":"publisher","unstructured":"Gauthier L, Dortet L, Cotellon G, Creton E, Cuzon G, Ponties V, et al. Diversity of carbapenemase-producing Escherichia coli isolates in France in 2012-2013. Antimicrob Agents Chemother. 2018;62. https:\/\/doi.org\/10.1128\/AAC.00266-18.","DOI":"10.1128\/AAC.00266-18"},{"key":"12186_CR50","doi-asserted-by":"publisher","first-page":"e0128120","DOI":"10.1371\/journal.pone.0128120","volume":"10","author":"HM Abdallah","year":"2015","unstructured":"Abdallah HM, Wintermans BB, Reuland EA, Koek A, Al Naiemi N, Ammar AM, et al. Extended-spectrum \u03b2-Lactamase- and carbapenemase-producing enterobacteriaceae isolated from Egyptian patients with suspected blood stream infection. PLoS One. 2015;10:e0128120. https:\/\/doi.org\/10.1371\/journal.pone.0128120.","journal-title":"PLoS One"},{"key":"12186_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12941-025-00780-0","volume":"24","author":"YG Andemichael","year":"2025","unstructured":"Andemichael YG, Habtetsion ET, Gulbet HH, Eman MH, Achila OO, Mengistu ST, et al. Major blood stream infection-causing bacterial pathogens, antimicrobial resistance patterns and trends: a multisite retrospective study in Asmara, Eritrea (2014\u20132022). Ann Clin Microbiol Antimicrob. 2025;24:15. https:\/\/doi.org\/10.1186\/s12941-025-00780-0.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"12186_CR52","doi-asserted-by":"publisher","first-page":"e1236","DOI":"10.1093\/cid\/ciac421","volume":"76","author":"E Weerdenburg","year":"2023","unstructured":"Weerdenburg E, Davies T, Morrow B, Zomer AL, Hermans P, Go O, et al. Global distribution of O serotypes and antibiotic Resistance in extraintestinal pathogenic Escherichia coli collected from the blood of patients with bacteremia across multiple surveillance studies. Clin Infect Dis. 2023;76:e1236\u201343. https:\/\/doi.org\/10.1093\/cid\/ciac421.","journal-title":"Clin Infect Dis"},{"key":"12186_CR53","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1093\/jac\/dkae182","volume":"79","author":"E Arconada Nuin","year":"2024","unstructured":"Arconada Nuin E, Vilken T, Xavier BB, Doua J, Morrow B, Geurtsen J, et al. A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli disease. J Antimicrob Chemother. 2024;79:2142\u201351. https:\/\/doi.org\/10.1093\/jac\/dkae182.","journal-title":"J Antimicrob Chemother"},{"key":"12186_CR54","unstructured":"European Centre for Disease Prevention and Control (ECDC). Surveillance atlas of infectious diseases. https:\/\/www.ecdc.europa.eu\/en\/surveillance-atlas-infectious-diseases."},{"key":"12186_CR55","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/jac\/dkt341","volume":"69","author":"R Skov","year":"2014","unstructured":"Skov R, Larsen AR, Kearns A, Holmes M, Teale C, Edwards G, et al. Phenotypic detection of mecC-MRSA: cefoxitin is more reliable than oxacillin. J Antimicrob Chemother. 2014;69:133\u201335. https:\/\/doi.org\/10.1093\/jac\/dkt341.","journal-title":"The J Antimicrob Chemother"},{"key":"12186_CR56","doi-asserted-by":"publisher","first-page":"e122.1","DOI":"10.1016\/j.cmi.2019.05.002","volume":"26","author":"R Skov","year":"2020","unstructured":"Skov R, Varga A, Matuschek E, \u00c5hman J, Bemis D, Bengtsson B, et al. EUCAST disc diffusion criteria for the detection of mecA-Mediated \u03b2-lactam resistance in Staphylococcus pseudintermedius: oxacillin versus cefoxitin. Clin Microbiol Infect. 2020;26:.e122.1\u201326. https:\/\/doi.org\/10.1016\/j.cmi.2019.05.002.","journal-title":"Clin Microbiol And Infect"},{"key":"12186_CR57","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jinf.2018.12.005","volume":"78","author":"TS Kramer","year":"2019","unstructured":"Kramer TS, Schr\u00f6der C, Behnke M, Aghdassi SJ, Geffers C, Gastmeier P, et al. Decrease of methicillin resistance in Staphylococcus aureus in nosocomial infections in Germany\u2013a prospective analysis over 10 years. J Infect. 2019;78:215\u201319. https:\/\/doi.org\/10.1016\/j.jinf.2018.12.005.","journal-title":"The J Infect"},{"key":"12186_CR58","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cmi.2015.04.017","volume":"21","author":"J-M Rolain","year":"2015","unstructured":"Rolain J-M, Abat C, Brouqui P, Raoult D. Worldwide decrease in methicillin-resistant Staphylococcus aureus: do we understand something? Clin Microbiol Infect. 2015;21:515\u201317. https:\/\/doi.org\/10.1016\/j.cmi.2015.04.017.","journal-title":"Clin Microbiol And Infect"},{"key":"12186_CR59","doi-asserted-by":"publisher","first-page":"214","DOI":"10.15585\/mmwr.mm6809e1","volume":"68","author":"AP Kourtis","year":"2019","unstructured":"Kourtis AP, Hatfield K, Baggs J, Mu Y, See I, Epson E, et al. Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections - United States. MMWR Morb Mortal Wkly Rep. 2019;68:214\u201319. https:\/\/doi.org\/10.15585\/mmwr.mm6809e1.","journal-title":"MMWR Morb. Mortal. Wkly. Rep"},{"key":"12186_CR60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","volume":"17","author":"NA Turner","year":"2019","unstructured":"Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019;17:203\u201318. https:\/\/doi.org\/10.1038\/s41579-018-0147-4.","journal-title":"Nat Rev Microbiol"},{"key":"12186_CR61","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2012\/4877.2671","author":"D Juyal","year":"2013","unstructured":"Juyal D. The prevalence of inducible clindamycin resistance among Staphylococci in a tertiary care hospital \u2013 a study from the Garhwal Hills of Uttarakhand, India. J Clin Diagnostic Res. 2013. https:\/\/doi.org\/10.7860\/JCDR\/2012\/4877.2671.","journal-title":"J Clin And Diagnostic Res"},{"key":"12186_CR62","doi-asserted-by":"publisher","first-page":"296","DOI":"10.47391\/JPMA.20-509","volume":"72","author":"F Arshad","year":"2022","unstructured":"Arshad F, Saleem S, Tahir R, Ghazal A, Khawaja A, Jahan S. Four year trend of antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in a tertiary care hospital, Lahore. J Pak Med Assoc. 2022;72:296\u201399. https:\/\/doi.org\/10.47391\/JPMA.20-509.","journal-title":"J Pak Med Assoc"},{"key":"12186_CR63","doi-asserted-by":"publisher","first-page":"e0308017","DOI":"10.1371\/journal.pone.0308017","volume":"19","author":"A Birhanu","year":"2024","unstructured":"Birhanu A, Amare A, Tigabie M, Getaneh E, Assefa M, Cherkos T, et al. Nasopharyngeal carriage, antimicrobial susceptibility patterns, and associated factors of gram-positive bacteria among children attending the outpatient department at the University of Gondar comprehensive specialized hospital, Northwest Ethiopia. PLoS One. 2024;19:e0308017. https:\/\/doi.org\/10.1371\/journal.pone.0308017.","journal-title":"PLoS One"},{"key":"12186_CR64","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13756-023-01291-3","volume":"12","author":"MA Belete","year":"2023","unstructured":"Belete MA, Gedefie A, Alemayehu E, Debash H, Mohammed O, Gebretsadik D, et al. The prevalence of vancomycin-resistant Staphylococcus aureus in Ethiopia: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2023;12:86. https:\/\/doi.org\/10.1186\/s13756-023-01291-3.","journal-title":"Antimicrob Resist Infect Control"},{"key":"12186_CR65","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.3201\/eid2110.141914","volume":"21","author":"D Panesso","year":"2015","unstructured":"Panesso D, Planet PJ, Diaz L, Hugonnet J-E, Tran TT, Narechania A, et al. Methicillin-susceptible, vancomycin-resistant Staphylococcus aureus. Braz Emerg Infect Dis. 2015;21:1844\u201348. https:\/\/doi.org\/10.3201\/eid2110.141914.","journal-title":"Braz Emerg Infect Dis"},{"key":"12186_CR66","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2147\/IDR.S363499","volume":"15","author":"N Kumar","year":"2022","unstructured":"Kumar N, Sen S. Effectiveness of disc diffusion method for vancomycin sensitivity testing of Staphylococcus aureus [Letter]. Infect Drug Resist. 2022;15:1027\u201328. https:\/\/doi.org\/10.2147\/IDR.S363499.","journal-title":"Infect Drug Resist"},{"key":"12186_CR67","doi-asserted-by":"publisher","unstructured":"Fabre V, Carroll KC, Cosgrove SE. Blood culture utilization in the hospital setting: a call for diagnostic stewardship. J Clin Microbiol. 2022;60. https:\/\/doi.org\/10.1128\/jcm.01005-21.","DOI":"10.1128\/jcm.01005-21"},{"key":"12186_CR68","unstructured":"WHO Regional Office for Europe\/European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2022\u20132020 data. Copenhagen; 2022."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12186-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12186-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12186-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T01:53:40Z","timestamp":1767059620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12186-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12186"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12186-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"28 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hence, the Ethics Committee of the Ministry of Health & Social Services has approved the study and gave a waiver of consent and participation (Ref: 17\/3\/3EHH) due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1824"}}